3-DIMENSIONAL CONFORMAL RADIATION-THERAPY MAY IMPROVE THE THERAPEUTICRATIO OF HIGH-DOSE RADIATION-THERAPY FOR LUNG-CANCER

Citation
Jg. Armstrong et al., 3-DIMENSIONAL CONFORMAL RADIATION-THERAPY MAY IMPROVE THE THERAPEUTICRATIO OF HIGH-DOSE RADIATION-THERAPY FOR LUNG-CANCER, International journal of radiation oncology, biology, physics, 26(4), 1993, pp. 685-689
Citations number
12
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
ISSN journal
03603016
Volume
26
Issue
4
Year of publication
1993
Pages
685 - 689
Database
ISI
SICI code
0360-3016(1993)26:4<685:3CRMIT>2.0.ZU;2-V
Abstract
Purpose: The specific aim of 3-dimensional conformal radiation therapy is to improve the target dose distribution while concomitantly reduci ng normal tissue dose. Such an approach should permit dose escalation until the limits of acceptable normal tissue toxicity are reached. To evaluate the feasibility of tumor dose escalation for nine patients wi th lung cancer, we determined the dose distribution to the target and normal tissues with 3-dimensional conformal radiation therapy and conv entional planning. Methods and Materials: Plans were compared to asses s adequacy of dose delivery to target volumes, dose-volume histograms for normal tissue, and normal tissue complication probabilities (NTCP) for nine patients with lung tumors. Results: The mean percentage of g ross disease which received less-than-or-equal-to 70.2 Gy with 3-dimen sional conformal radiation therapy (3DCRT) was 40% of the mean percent age of gross disease which received less-than-or-equal-to 70.2 Gy with conventional treatment planning (CTP). The mean NTCP for lung parench yma with 3DCRT was 36% of the mean NTCP with CTP. The mean esophageal NTCP with 3DCRT was 88% of the mean NTCP with CTP. Conclusion: This pr eliminary analysis suggests that three dimensional conformal radiation therapy may provide superior delivery of high dose radiation with red uced risk to normal tissue, suggesting that this approach may have the potential to improve the therapeutic ratio of high dose radiation the rapy for lung cancer.